TMC114-TiDP29-C228 - A Safety Study to Evaluate the Antiviral Activity of Darunavir (DRV) in Combination With Ritonavir (Rtv) in HIV 1 Infected Children From 3 Years to Below 6 Years of Age
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by Tibotec Pharmaceuticals, Ireland.
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Tibotec Pharmaceuticals, Ireland
Collaborator:
Tibotec Pharmaceutical Limited
Information provided by:
Tibotec Pharmaceuticals, Ireland
ClinicalTrials.gov Identifier:
NCT00919854
First received: June 11, 2009
Last updated: February 10, 2011
Last verified: February 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | February 2011 |
| Primary Completion Date: | August 2010 (Final data collection date for primary outcome measure) |